Article

Retinal vein occlusion risk may be increased by high blood pressure and cholesterol, say researchers

High blood pressure and high cholesterol may be connected to an increased risk of retinal vein occlusion, according to a study conducted by researchers at the Royal College of Surgeons.

Dublin-High blood pressure and high cholesterol may be connected to an increased risk of retinal vein occlusion, according to a study conducted by researchers at the Royal College of Surgeons.

Pooling data from 21 previously published studies involving 2,916 individuals with retinal vein occlusion and 28,646 participants without the condition, 63.6 % had hypertension compared with 36.2% of the controls.

High cholesterol levels were more than twice as common among patients with retinal vein occlusion as those without, and those with high cholesterol had an approximately 2.5-fold higher risk of retinal vein occlusion. Diabetes was slightly more prevalent among those with retinal vein occlusion than among those with out.

"Accordingly, we recommend that an assessment of blood pressure and both fasting lipid and glucose levels be routinely performed in adults with any form of retinal vein occlusion," wrote the authors. "Those who treat patients with systemic hypertension, diabetes mellitus, and hyperlipidemia should consider that each poses a risk not only to cardiovascular health but also to ocular health."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.